Amyotrophic Lateral Sclerosis

Show Articles
Journal Properties
  • Continued as
    Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  • Language
    English
  • Number of Articles
    866
  • ISSN
    1748-2968
  • e-ISSN
    1471-180X
  • Main Publisher
    Taylor & Francis
  • Publisher
    Informa UK Limited
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Description
Amyotrophic Lateral Sclerosis (ALS) journal is dedicated to advancing research and understanding of this devastating neurodegenerative disease. It provides a platform for disseminating cutting-edge findings on the diagnosis, pathogenesis, and management of ALS and related motor neuron disorders. This journal covers a broad spectrum of topics, including clinical trials, genetic studies, biomarker discovery, and the development of novel therapeutic strategies. The journal welcomes contributions from diverse disciplines such as neurology, neuroscience, genetics, and rehabilitation medicine. It aims to bridge the gap between basic science and clinical practice, serving as a valuable resource for researchers, clinicians, and healthcare professionals involved in ALS care. With a focus on improving patient outcomes and quality of life, ALS promotes collaboration and knowledge sharing among the ALS research community. It encourages submissions of original research articles, reviews, and case reports. By contributing to the global effort to combat ALS, the journal plays a vital role in accelerating the discovery of effective treatments and ultimately finding a cure.